Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Acadia Reiterates 2024 Guidance

Author: Benzinga Newsdesk | May 08, 2024 04:43pm

Acadia is reiterating all of its 2024 guidance provided on February 27, 2024.

  • DAYBUE net product sales guidance in the range of $370 to $420 million.
  • NUPLAZID net product sales guidance in the range of $560 to $590 million.
  • R&D expense in the range of $305 to $325 million.
  • SG&A expense in the range of $455 to $480 million.

Posted In: ACAD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist